InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: geocappy1 post# 126582

Friday, 06/07/2013 11:51:19 AM

Friday, June 07, 2013 11:51:19 AM

Post# of 346050
If they work with Peregrine in the form of interest free loan...that would be a bonus. Maybe a Grant of $100 Million from the BMGF in exchange for some shelf shares at these prices. Would prefer the interest free loan so no dilution but BMGF could certainly afford to hand over much more. I have a feeling if they were aware of the data they would certainly work with Peregrine as well. BMGF like to assist where health care is lacking....so some trial could be worked out with them.

Out of the box .. How about having a foundation sponsor behind Bavi...sort of like marketing/advertising/name recognition for the BMGF? That may not fly with a future partner but if they dont "own" Peregrine as in buyout, what would stop Peregrine from taking say $100M allowing the BMGF to become globally marketed wherever Bavi goes. If the BMGF has a marketing/advertisement budget....use that to assist Bavi...as they will gain global recognition and marketing behind what could be the future of oncology.

Out of the box agreements likr this Peregrine can do to shore up money now....and create an entirely new revenue stream never before seen in even Big Pharma.

GLTA!

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News